Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Queensland Health
QuintilesIMS
Colorcon
US Army
US Department of Justice
Medtronic
Julphar
Cantor Fitzgerald

Generated: April 23, 2018

DrugPatentWatch Database Preview

RIMACTANE Drug Profile

« Back to Dashboard

When do Rimactane patents expire, and when can generic versions of Rimactane launch?

Rimactane is a drug marketed by Oxford Pharms and is included in one NDA.

The generic ingredient in RIMACTANE is rifampin. There are nine drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the rifampin profile page.
Drug patent expirations by year for RIMACTANE
Synonyms for RIMACTANE
(2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-5,6,9,17,19-Pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-[[(4-methylpiperazin-1-yl)imino]methyl]-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca
(2S,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-5,6,9,17,19-Pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-{[(4-methylpiperazin-1-yl)imino]methyl}-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[
(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-{(E)-[(4-methylpiperazin-1-yl)imino]methyl}-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1(4,7).0(5,28)]
[1,11,13]trienimino)naphto[2,1-b]furan-21-yl acetate
[pentahydroxy-methoxy-heptamethyl-[(E)-(4-methylpiperazin-1-yl)iminomethyl]-dioxo-[?]yl] acetate
13292-46-1
2,11,13]trienimino)naphtho[2,1-b]furan-1,11(2H)-dione, 5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-[N-(4-methyl-1-piperazinyl)formimidoyl]-, 21-acetate
2,7-(epoxy[1,11,13]pentadecatrienoimino)naphtho[2,1-b]furan-1,11(2H)-dione, 21-(acetyloxy)-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-[(E)-[(4-methyl-1-piperazinyl)imino]meth
2,7-(Epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,11(2H)-dione, 5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-(N-(4-methyl-1-piperazinyl)formimidoyl)-, 21-acetate (
2,7-(Epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,11(2H)-dione, 5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-(N-(4-methyl-1-piperazinyl)formimidoyl)-, 21-acetate (8CI)
26-[(1E)-2-(4-methylpiperazinyl)-2-azavinyl](7S,11S,13S,17S,18S,12R,14R,15R,16 R)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-d ioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1<
3-(((4-methyl-1-piperazinyl)imino)methyl)-Rifamycin
3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV
3-([(4-Methyl-1-piperazinyl)imino]methyl)rifamycin SV
3-(4-Methylpiperazinyliminomethyl)-rifamycin SV
3-(4-Methylpiperazinyliminomethyl)rifamycin SV
3-[(4-Methyl-1-piperazinyl)iminomethyl]rifamycin SV
3-[[(4-Methyl-1-piperazinyl)imino]-methyl]rifamycin
4,7>.0<5,28>]triaconta-1(28),2,4,9,1 9,21,25(29),26-octaen-13-yl acetate
5,6,9,17,19,21-Hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-(N-(4-methyl-1-piperazinyl)formimidoyl)-2,7-(epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,11(2H)-dione 21-acetate
5,6,9,17,19,21-Hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-(N-(4-methyl-1-piperazinyl)formimidoyl)-2,7-(epoxypentadeca(1,11,13)trienimino)naphtho(2,1-beta)furan-1,11(2H)-dione 21-acetate
5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-[N-(4-methyl-1-piperazinyl)formimidoyl]-, 21-acetate
8-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV
8-(4-Methylpiperazinyliminomethyl) rifamycin SV
8-[[(4-Methyl-1-piperazinyl)imino[methyl]rifamycin
8-[[(4-Methyl-1-piperazinyl)imino]methyl]rifamycin sv
8-[[(4-Methylpiperazinyl)imino]methyl]rifamycin sv
8CI)
AB1009526
Abrifam
AKOS015951372
AN-11924
Archidyn
Arficin
Arzide
Ba 41166
Ba 41166/E
BA-41166E
BDBM200235
BDBM50370232
Benemicin
C06688
CCG-208267
CCRIS 551
CHEBI:28077
cid_5381226
D00211
DB01045
Dione 21-acetate
Doloresum
DRG-0109
EINECS 236-312-0
Eremfat
Famcin
Fenampicin
HMS1569J11
HSDB 3181
KSC-233-049
KUC109578N
L-5103
L-5103 Lepetit
MFCD00151389
NSC 113926
NSC-113926
NSC113926
Piperine & Rifampicin
Prestwick_833
R-Cin
R/AMP
Refampicin
Reserpine & Rifampicin
RFP
RIF
Rifa
Rifadin
Rifadin (TN)
Rifadin I.V.
Rifadine
Rifagen
Rifaldazin
Rifaldazine
Rifaldin
Rifam
rifamcin
Rifamor
Rifampicin
Rifampicin (JP17/INN)
Rifampicin [INN:BAN:JAN]
Rifampicin & EEP
Rifampicin & Propolis
Rifampicin SV
Rifampicin, >=97.0% (HPLC)
Rifampicin, >=97% (HPLC), powder
Rifampicin, European Pharmacopoeia (EP) Reference Standard
Rifampicin, plant cell culture tested, BioReagent, >=97% (HPLC), crystalline
Rifampicin, powder, gamma-irradiated
Rifampicin, VETRANAL(TM), analytical standard
Rifampicina
Rifampicina [INN-Spanish]
Rifampicine
Rifampicine [French]
Rifampicinum
Rifampicinum [INN-Latin]
rifampin
Rifampin (USP)
Rifampin [USAN:USP]
Rifampin, Molecular Biology Grade
Rifampin, pharmaceutical secondary standard; traceable to USP, PhEur
Rifampin, United States Pharmacopeia (USP) Reference Standard
Rifamsolin
Rifamycin AMP
Rifamycin, 3-(((4-methyl-1-piperazinyl)imino)methyl)-
Rifamycin, 3-[[(4-methyl-1-piperazinyl)imino]methyl]-
Rifaprodin
Rifcin
Rifinah
Rifobac
Rifoldin
Rifoldine
Rifomycin SV, 8-(N-(4-methyl-1-piperazinyl)formidoyl)-
Rifomycin sv, 8-[N-(4-Methyl-1-piperazinyl)formidoyl]-
Riforal
Rimactan
Rimactane (TN)
Rimactazid
Rimactizid
Rimazid
RMP
SCHEMBL19627083
Sinerdol
ST057531
Stereoisomer of 5,9,17,19,21-Hexahydroxy-23-methoxy-2,4,12,16,18,20,22-he@ptamethyl-8-[N-(4-methyl-1-piperazinyl)formimidoyl]-2,7-(epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-1,11(2H)-dione 21-acetate
Tubocin
UNII-VJT6J7R4TR
VJT6J7R4TR
WLN: V1 WQ A&1 E&1 E1UN- AT6N DNTJ D1
yl]-, (2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-

US Patents and Regulatory Information for RIMACTANE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Oxford Pharms RIMACTANE rifampin CAPSULE;ORAL 050429-001 Approved Prior to Jan 1, 1982 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Fuji
Johnson and Johnson
Farmers Insurance
Cerilliant
AstraZeneca
Baxter
Express Scripts
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.